Literature DB >> 14769130

Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.

Ian H Batty1, Ian N Fleming, C Peter Downes.   

Abstract

In 1321N1 astrocytoma cells, stimulation of the IGF-1 (insulin-like growth factor-1) receptor increased the association of PI3K [phosphoinositide (PI) 3-kinase] activity with IRS-1 (insulin re-ceptor substrate 1), and increased the cellular concentration of PtdIns(3,4,5)P3. Carbachol, acting on M3 muscarinic receptors, inhibited insulin-, but not PDGF (platelet-derived growth factor)-, stimulated responses by approximately 50%. The inhibition of IRS-1-associated PI3K activity by carbachol (i) was rapid (<1 min), persistent (> or =60 min) and potent (half-maximal concentration approximately 1 microM); (ii) was reproduced by stimuli for several phospholipase-C-coupled receptors; (iii) was prevented by the inhibition of protein kinase C, but not by chelation of intracellular Ca2+; and (iv) was not blocked or reproduced by inhibitors or stimuli respectively of mitogen-activated protein kinase, PI3K, protein kinase B or the mammalian target of rapamycin. However, the effects of carbachol were prevented by sodium vanadate, a protein tyrosine phosphatase inhibitor, and were accompanied by reduced insulin-stimulated IRS-1 tyrosine phosphorylation and recruitment of the 85 kDa regulatory subunit of PI3K to IRS-1, but not by reduced IGF-1 receptor kinase activity. The inhibitory effect of carbachol was reproduced by okadaic acid, a protein serine/threonine phosphatase inhibitor, but not by PDGF, yet all three agents stimulated the serine phosphorylation of IRS-1 at residues Ser312, Ser616 and Ser636/639, albeit to different extents. Thus muscarinic receptors may inhibit insulin signalling by promoting IRS-1 tyrosine dephosphorylation and/or by uncoupling IRS-1 from the stimulated IGF-1 receptor by stimulating IRS-1 serine phosphorylation. However, the proportion of IRS-1 molecules phosphorylated at a particular site or the phosphorylation of additional IRS-1 serine residues other than those noted above must be important.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14769130      PMCID: PMC1224131          DOI: 10.1042/BJ20031700

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  53 in total

Review 1.  Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors.

Authors:  K Siddle; B Ursø; C A Niesler; D L Cope; L Molina; K H Surinya; M A Soos
Journal:  Biochem Soc Trans       Date:  2001-08       Impact factor: 5.407

2.  Insulin stimulates PKCzeta -mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins.

Authors:  Y F Liu; K Paz; A Herschkovitz; A Alt; T Tennenbaum; S R Sampson; M Ohba; T Kuroki; D LeRoith; Y Zick
Journal:  J Biol Chem       Date:  2001-01-29       Impact factor: 5.157

3.  Scabronine G-methylester enhances secretion of neurotrophic factors mediated by an activation of protein kinase C-zeta.

Authors:  Y Obara; H Kobayashi; T Ohta; Y Ohizumi; N Nakahata
Journal:  Mol Pharmacol       Date:  2001-05       Impact factor: 4.436

4.  Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways.

Authors:  L Rui; V Aguirre; J K Kim; G I Shulman; A Lee; A Corbould; A Dunaif; M F White
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

5.  Insulin resistance: a phosphorylation-based uncoupling of insulin signaling.

Authors:  Y Zick
Journal:  Trends Cell Biol       Date:  2001-11       Impact factor: 20.808

6.  Activation of mitogen-activated protein kinase by muscarinic receptors in astroglial cells: role in DNA synthesis and effect of ethanol.

Authors:  K Yagle; H Lu; M Guizzetti; T Möller; L G Costa
Journal:  Glia       Date:  2001-08       Impact factor: 7.452

7.  Insulin signalling and the regulation of glucose and lipid metabolism.

Authors:  A R Saltiel; C R Kahn
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

Review 8.  Inhibitors of protein kinases and phosphatases.

Authors:  C MacKintosh; R W MacKintosh
Journal:  Trends Biochem Sci       Date:  1994-11       Impact factor: 13.807

9.  Muscarinic receptors mediate phospholipase C-dependent activation of protein kinase B via Ca2+, ErbB3, and phosphoinositide 3-kinase in 1321N1 astrocytoma cells.

Authors:  Xiuwen Tang; Ian H Batty; C Peter Downes
Journal:  J Biol Chem       Date:  2001-11-01       Impact factor: 5.157

10.  Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin.

Authors:  L V Ravichandran; D L Esposito; J Chen; M J Quon
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

View more
  9 in total

1.  A screen for novel phosphoinositide 3-kinase effector proteins.

Authors:  Miles J Dixon; Alexander Gray; François-Michel Boisvert; Mark Agacan; Nicholas A Morrice; Robert Gourlay; Nicholas R Leslie; C Peter Downes; Ian H Batty
Journal:  Mol Cell Proteomics       Date:  2011-01-24       Impact factor: 5.911

2.  Galphaq binds to p110alpha/p85alpha phosphoinositide 3-kinase and displaces Ras.

Authors:  Lisa M Ballou; Mohar Chattopadhyay; Yan Li; Suzanne Scarlata; Richard Z Lin
Journal:  Biochem J       Date:  2006-03-15       Impact factor: 3.857

3.  The control of phosphatidylinositol 3,4-bisphosphate concentrations by activation of the Src homology 2 domain containing inositol polyphosphate 5-phosphatase 2, SHIP2.

Authors:  Ian H Batty; Jeroen van der Kaay; Alex Gray; Joan F Telfer; Miles J Dixon; C Peter Downes
Journal:  Biochem J       Date:  2007-10-15       Impact factor: 3.857

4.  Mechanism of activation of PKB/Akt by the protein phosphatase inhibitor Calyculin A.

Authors:  Mercedes Pozuelo-Rubio; Nick R Leslie; Jane Murphy; Carol Mackintosh
Journal:  Cell Biochem Biophys       Date:  2010-12       Impact factor: 2.194

5.  Integration of P2Y receptor-activated signal transduction pathways in G protein-dependent signalling networks.

Authors:  Kristof Van Kolen; Herman Slegers
Journal:  Purinergic Signal       Date:  2006-06-07       Impact factor: 3.765

6.  Leptin and insulin stimulation of signalling pathways in arcuate nucleus neurones: PI3K dependent actin reorganization and KATP channel activation.

Authors:  Shirin Mirshamsi; Hilary A Laidlaw; Ke Ning; Erin Anderson; Laura A Burgess; Alexander Gray; Calum Sutherland; Michael L J Ashford
Journal:  BMC Neurosci       Date:  2004-12-06       Impact factor: 3.288

7.  Type 3 muscarinic acetylcholine receptor stimulation is a determinant of endothelial barrier function and adherens junctions integrity: role of protein-tyrosine phosphatase 1B.

Authors:  Zhou-Yang Jiao; Jing Wu; Chao Liu; Bing Wen; Wen-Zeng Zhao; Xin-Ling Du
Journal:  BMB Rep       Date:  2014-10       Impact factor: 4.778

8.  PKD1 mediates negative feedback of PI3K/Akt activation in response to G protein-coupled receptors.

Authors:  Yang Ni; James Sinnett-Smith; Steven H Young; Enrique Rozengurt
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

9.  Loss of PTEN selectively desensitizes upstream IGF1 and insulin signaling.

Authors:  J Lackey; J Barnett; L Davidson; I H Batty; N R Leslie; C P Downes
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.